Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity

NCT03378960 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Bariatric Surgery Candidate

Interventions

DRUG: Omeprazole 20mg

Sponsor

Emilio Vargas Castrillón

Collaborators

[object Object]